Annual Cash & Cash Equivalents
$233.00M$18.10M-7.21%
Summary
- Current Value
- As of today, NBIX annual cash & cash equivalents is $233.00M, down -7.21% on
- Historical Performance
- NBIX annual cash & cash equivalents is down -31.63% over the past 3 years, and up +107.48% over the past 5 years
- All-Time High Comparison
- NBIX annual cash & cash equivalents is currently -31.63% below its historical high of $340.80M set on
- 3-Year Low Comparison
- NBIX annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- NBIX annual cash & cash equivalents is higher than 80.44% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $233.00M | -7.2% | -31.6% | +107.5% | +524.2% | |
| Quarterly Cash & Cash Equivalents | $1.11B | -9.2% | +39.5% | +18.0% | – | |
| Price | $140.62 | +2.2% | +14.3% | +36.8% | +1777.4% | |
| Annual Current Assets | $1.72B | +7.3% | +77.3% | +107.5% | +3013.9% | |
| Annual Total Liabilities | $1.26B | +14.5% | +80.0% | +87.9% | +1780.4% | |
| Annual Working Capital | $1.22B | +27.8% | +67.4% | +358.0% | +3335.3% | |
| Annual Net Income | $341.30M | +36.7% | +280.9% | +822.1% | +768.7% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $262.90M | N/A | -11.4% |
| 5Y | $340.80M | -31.6% | |
| All | $340.80M | -31.6% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $233.00M | at low | |
| 5Y | $187.10M | N/A | +24.5% |
| All | $11.30M | +1962.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of NBIX?
As of today, NBIX annual cash & cash equivalents is $233.00M
What is 1-year change in NBIX annual cash & cash equivalents?
NBIX annual cash & cash equivalents is down -7.21% year-over-year
What is 3-year change in NBIX annual cash & cash equivalents?
NBIX annual cash & cash equivalents is down -31.63% over the past 3 years
How far is NBIX annual cash & cash equivalents from its all-time high?
NBIX annual cash & cash equivalents is currently -31.63% below its historical high of $340.80M set on December 31, 2021
How does NBIX annual cash & cash equivalents rank versus sector peers?
NBIX annual cash & cash equivalents is higher than 80.44% of companies in Healthcare sector
When is NBIX next annual earnings release?
The next annual earnings release for NBIX is on
Quarterly Cash & Cash Equivalents
$1.11B$139.20M+14.27%
Summary
- Current Value
- As of today, NBIX quarterly cash & cash equivalents is $1.11B, up +14.27% on
- Historical Performance
- NBIX quarterly cash & cash equivalents is down -9.22% year-over-year, and up +39.45% over the past 3 years
- All-Time High Comparison
- NBIX quarterly cash & cash equivalents is currently -9.22% below its historical high of $1.23B set on
- 3-Year Low Comparison
- NBIX quarterly cash & cash equivalents is +24.61% above its 3-year low of $894.60M reached on
- Sector Comparison
- NBIX quarterly cash & cash equivalents is higher than 93.69% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $1.11B | +14.3% | -9.2% | +39.5% | +18.0% | |
| Annual Cash & Cash Equivalents | $233.00M | – | -7.2% | -31.6% | +107.5% | |
| Price | $140.62 | +2.6% | +2.2% | +14.3% | +36.8% | |
| Quarterly Current Assets | $2.16B | +23.4% | +15.0% | +79.0% | +86.6% | |
| Quarterly Total Liabilities | $1.26B | +5.6% | +54.6% | +110.8% | +80.7% | |
| Quarterly Working Capital | $1.52B | +26.4% | +5.1% | +111.0% | +178.5% | |
| Quarterly Net Income | $209.50M | +94.9% | +61.4% | +205.8% | +463.7% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.11B | at high | |
| 3Y | $1.23B | -9.2% | |
| 5Y | $1.23B | -9.2% | |
| All | $1.23B | -9.2% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $943.50M | +18.2% | |
| 3Y | $894.60M | +24.6% | |
| 5Y | $648.30M | +72.0% | |
| All | $7.20M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of NBIX?
As of today, NBIX quarterly cash & cash equivalents is $1.11B
What is NBIX quarterly cash & cash equivalents most recent change?
NBIX quarterly cash & cash equivalents was up +14.27% on September 30, 2025
What is 1-year change in NBIX quarterly cash & cash equivalents?
NBIX quarterly cash & cash equivalents is down -9.22% year-over-year
How far is NBIX quarterly cash & cash equivalents from its all-time high?
NBIX quarterly cash & cash equivalents is currently -9.22% below its historical high of $1.23B set on September 30, 2024
How does NBIX quarterly cash & cash equivalents rank versus sector peers?
NBIX quarterly cash & cash equivalents is higher than 93.69% of companies in Healthcare sector
When is NBIX next earnings release?
The next earnings release for NBIX is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- NBIX Official Website www.neurocrine.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/914475/000091447525000181/0000914475-25-000181-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/914475/000091447525000037/0000914475-25-000037-index.htm
- NBIX Profile on Yahoo Finance finance.yahoo.com/quote/NBIX
- NBIX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nbix